Current U.S. guidelines limit BRCA1/2 genetic testing to individuals with a personal or family history of a relevant cancer, including early-onset breast cancer, multiple primary breast cancers, ovarian cancer, and certain other cancers1,2,4. This evidence concerns the gene BRCA1 and ovarian cancer.